Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Non-Current Deffered Revenue: 2020-2021

Historic Non-Current Deffered Revenue for Terns Pharmaceuticals (TERN) over the last 2 years, with Dec 2021 value amounting to $160,000.

  • Terns Pharmaceuticals' Non-Current Deffered Revenue fell 27.27% to $160,000 in Q4 2021 from the same period last year, while for Dec 2021 it was $160,000, marking a year-over-year decrease of 27.27%. This contributed to the annual value of $160,000 for FY2021, which is 27.27% down from last year.
  • Per Terns Pharmaceuticals' latest filing, its Non-Current Deffered Revenue stood at $160,000 for FY2021, which was down 27.27% from $220,000 recorded in FY2020.
  • Terns Pharmaceuticals' Non-Current Deffered Revenue's 5-year high stood at $220,000 during FY2020, with a 5-year trough of $160,000 in FY2021.
  • For the 2-year period, Terns Pharmaceuticals' Non-Current Deffered Revenue averaged around $190,000, with its median value being $190,000 (2020).
  • Data for Terns Pharmaceuticals' Non-Current Deffered Revenue shows a maximum YoY declined of 27.27% (in 2021) over the last 5 years.
  • Over the past 2 years, Terns Pharmaceuticals' Non-Current Deffered Revenue (Yearly) stood at $220,000 in 2020, then fell by 27.27% to $160,000 in 2021.